246 related articles for article (PubMed ID: 33312958)
1. RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis.
Saleh R; Sasidharan Nair V; Al-Dhaheri M; Khawar M; Abu Nada M; Alajez NM; Elkord E
Front Oncol; 2020; 10():604906. PubMed ID: 33312958
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer.
Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E
Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic Analyses of Myeloid-Derived Suppressor Cell Subsets in the Circulation of Colorectal Cancer Patients.
Sasidharan Nair V; Saleh R; Toor SM; Alajez NM; Elkord E
Front Oncol; 2020; 10():1530. PubMed ID: 32984004
[TBL] [Abstract][Full Text] [Related]
4. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma.
Wang Y; Sun H; Zhu N; Wu X; Sui Z; Gong L; Yu Z
Front Oncol; 2021; 11():640080. PubMed ID: 33854974
[TBL] [Abstract][Full Text] [Related]
6. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphoma.
Pu LF; Li MM; Feng XJ; Zhang T; Hu LH; Zheng HM; Charwudzi A; Ding YY; Liu J; Liu ZL; Xiong SD
J Leukoc Biol; 2024 May; 115(6):1094-1107. PubMed ID: 38369808
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells.
Goulart MR; Hlavaty SI; Chang YM; Polton G; Stell A; Perry J; Wu Y; Sharma E; Broxholme J; Lee AC; Szladovits B; Turmaine M; Gribben J; Xia D; Garden OA
Sci Rep; 2019 Mar; 9(1):3574. PubMed ID: 30837603
[TBL] [Abstract][Full Text] [Related]
9. Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer.
Okła K; Czerwonka A; Wawruszak A; Bobiński M; Bilska M; Tarkowski R; Bednarek W; Wertel I; Kotarski J
Front Immunol; 2019; 10():691. PubMed ID: 31001284
[TBL] [Abstract][Full Text] [Related]
10. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression.
Yin K; Xia X; Rui K; Wang T; Wang S
Front Oncol; 2020; 10():610104. PubMed ID: 33384962
[TBL] [Abstract][Full Text] [Related]
12. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V
Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574
[TBL] [Abstract][Full Text] [Related]
13. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma.
Yokota S; Yonezawa T; Momoi Y; Maeda S
Vet Immunol Immunopathol; 2024 Mar; 269():110716. PubMed ID: 38308864
[TBL] [Abstract][Full Text] [Related]
14. Treatment with lentiviral vectors encoding shRNA against interleukin 10 modulates the immunosuppressive activity of murine colon carcinoma-associated myeloid-derived suppressor cells.
Anger-Góra N; Węgierek-Ciura K; Szczygieł A; Mierzejewska J; Pajtasz-Piasecka E; Rossowska J
Oncol Lett; 2021 Aug; 22(2):582. PubMed ID: 34122633
[TBL] [Abstract][Full Text] [Related]
15. CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients.
Karakasheva TA; Dominguez GA; Hashimoto A; Lin EW; Chiu C; Sasser K; Lee JW; Beatty GL; Gabrilovich DI; Rustgi AK
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563330
[TBL] [Abstract][Full Text] [Related]
16. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.
Movahedi K; Guilliams M; Van den Bossche J; Van den Bergh R; Gysemans C; Beschin A; De Baetselier P; Van Ginderachter JA
Blood; 2008 Apr; 111(8):4233-44. PubMed ID: 18272812
[TBL] [Abstract][Full Text] [Related]
17. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
Binsfeld M; Muller J; Lamour V; De Veirman K; De Raeve H; Bellahcène A; Van Valckenborgh E; Baron F; Beguin Y; Caers J; Heusschen R
Oncotarget; 2016 Jun; 7(25):37931-37943. PubMed ID: 27177328
[TBL] [Abstract][Full Text] [Related]
18. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer.
de Goeje PL; Bezemer K; Heuvers ME; Dingemans AC; Groen HJ; Smit EF; Hoogsteden HC; Hendriks RW; Aerts JG; Hegmans JP
Oncoimmunology; 2015 Jul; 4(7):e1014242. PubMed ID: 26140237
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets.
Al-Mterin MA; Elkord E
Explor Target Antitumor Ther; 2022; 3(4):497-510. PubMed ID: 36081407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]